Page last updated: 2024-11-05

ticlopidine and Hemolysis

ticlopidine has been researched along with Hemolysis in 2 studies

Ticlopidine: An effective inhibitor of platelet aggregation commonly used in the placement of STENTS in CORONARY ARTERIES.
ticlopidine : A thienopyridine that is 4,5,6,7-tetrahydrothieno[3,2-c]pyridine in which the hydrogen attached to the nitrogen is replaced by an o-chlorobenzyl group.

Hemolysis: The destruction of ERYTHROCYTES by many different causal agents such as antibodies, bacteria, chemicals, temperature, and changes in tonicity.

Research Excerpts

ExcerptRelevanceReference

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gremmel, T1
Fedrizzi, S1
Weigel, G1
Eichelberger, B1
Panzer, S1
Katoh, M1
Karasawa, T1
Doi, H1
Odawara, A1

Other Studies

2 other studies available for ticlopidine and Hemolysis

ArticleYear
Underlying mechanism and specific prevention of hemolysis-induced platelet activation.
    Platelets, 2017, Volume: 28, Issue:6

    Topics: Adenosine Diphosphate; Adult; Aged; Apyrase; Blood Group Incompatibility; Blood Platelets; Clopidogr

2017
Effects of the antiplatelet agent TA-993 and its metabolite MB3 on the hemorheological properties of rat and human erythrocytes.
    Thrombosis research, 2001, Oct-15, Volume: 104, Issue:2

    Topics: Animals; Aspirin; Blood Viscosity; Diltiazem; Dose-Response Relationship, Drug; Erythrocytes; Hemoly

2001